ADDEX THERAPEUTICS LTD |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.758 USD | -2.78% |
|
-6.41% | +28.23% |
| Jun. 06 | Transcript : Addex Therapeutics Ltd, Q1 2024 Earnings Call, Jun 06, 2024 | |
| Jun. 06 | Addex Therapeutics' Q1 Net Loss Widens; Revenue Down | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 46.93B | - | |||||
| 39.08B | ||||||
| 38.48B | ||||||
| 31.01B | - | |||||
| 26.14B |
